Abstract: Disclosed is a DNA methylation signature in Peripheral Blood Mononuclear cells (PBMC) for predicting hepatocellular carcinoma (HCC) stages and chronic hepatitis, which is CG IDs. This invention also disclosed kits and uses for the DNA methylation signature.
Type:
Application
Filed:
June 23, 2016
Publication date:
November 14, 2019
Applicants:
Beijing Youan Hospital, Captical Medical University
Inventors:
Moshe SZYF, Ning LI, Yonghong ZHANG, Sophie PETROPOULOS